Iron deficiency anemia
Conditions
Interventions
Tiral Group:Iron-fortified gummy intake ,2 pills after each of your three meals, 6 in total, for 56 days straight
Sponsors
Qingdao Central Hospital, University of Health and Rehabilitation Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: 1.Women with hemoglobin levels of 90–120 g/L who opt for dietary adjustments and decline medication; 2.Serum ferritin level <30 µg/L; 3.Aged 18–40 years (inclusive); 4.During the trial, participants agree not to take any iron supplements or medications other than those specified in the protocol; 5.Participants agree not to enroll in any other interventional clinical studies during the trial period; 6.Participants agree not to undergo any cosmetic medical procedures during the trial period; 7.Voluntarily agree to participate in the trial, sign the informed consent form prior to the trial, fully understand the trial content, procedures, and potential adverse reactions, and are willing to comply with the trial requirements and protocols.
Exclusion criteria
Exclusion criteria: 1.Exclude those with anemia caused by digestive system diseases, gynecological diseases, urological diseases, respiratory system diseases, blood donation, or iatrogenic blood loss; 2.Exclude women who are planning pregnancy, currently pregnant, or lactating; 3.Exclude those who have undergone gastrointestinal surgery; 4.Exclude those with diseases or conditions of the blood, immune, respiratory, gastrointestinal, biliary, renal and urinary, neurological and musculoskeletal systems, psychiatric disorders, thyroid diseases, as well as acute or chronic infectious diseases and their complications; 5.In the past three months, have you been dieting, engaging in excessive exercise, or taking diet pills or appetite suppressants; 6.Current or past abuse of alcohol, drugs, or supplements that may cause intestinal dysfunction or affect product evaluation; 7.Smoking more than 10 cigarettes per day; 8.Have had more than 2 episodes of diarrhea in the past two weeks, or have used laxatives or other gastrointestinal medications; 9.Have used iron-containing medications or nutritional supplements in the past two weeks; 10.Presence of a skin condition that may interfere with the evaluation of the test results; 11.Known allergy to the test components, history of drug allergies, or allergic diseases; 12.Any other condition that, in the investigator's judgment, may preclude participation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hemoglobin; | — |
Secondary
| Measure | Time frame |
|---|---|
| Serum Iron, Total Iron Binding Capacity, Serum Ferritin, Mean Corpuscular Volume, Mean Corpuscular Hemoglobin, Mean Corpuscular Hemoglobin Concentration, Reticulocyte Count;Skin Peak Systolic Velocity;Score of the Self-Rating Scale of Sleep (SRSS);Quantified Grading Score for Symptoms of Qi-Blood Deficiency Syndrome;Adverse events , abnormal changes in laboratory examinations, and results of the Gastrointestinal Symptom Rating Scale (GSRS).;36-Item Short Form Health Survey;Facial color (L value, a value, b* value, ITA° value);Self-rated scores for facial redness & ruddy level, dullness, and radiance;Physician-rated scores of facial ruddy level, dullness and radiance; | — |
Countries
China
Contacts
Public ContactLingling Song
Qingdao Central Hospital, University of Health and Rehabilitation Sciences
Outcome results
None listed